Skip to main content
. 2018 Jul 31;9:1717. doi: 10.3389/fimmu.2018.01717

Figure 3.

Figure 3

Geographical distribution of ongoing chimeric antigen receptor (CAR) T cell therapy clinical trials for cancer. USA and China hold most of the trials; however, other countries have also considered holding trials. Created by Esmaeilzadeh et al.